An experienced manager and a sensible quality-first investment process makes Fidelity International Discovery an attractive offering for an investor seeking large-cap international growth exposure.
Fidelity International Discovery FIGRX
- NAV / 1-Day Return 53.41 / +2.18 %
- Total Assets 10.3 Bil
-
Adj. Expense Ratio
0.620%
- Expense Ratio 0.620%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category Foreign Large Growth
- Investment Style Large Growth
- Min. Initial Investment 0
- Status Open
- TTM Yield 1.61%
- Turnover 49%
USD | NAV as of Sep 26, 2024 | 1-Day Return as of Sep 26, 2024, 10:09 PM GMT+0
Morningstar’s Analysis FIGRX
Will FIGRX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 22.0
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Fidelity Cash Central Fund | 3.80 | 377.0 Mil | Cash and Equivalents |
Novo Nordisk A/S Class B | 3.37 | 334.5 Mil | Healthcare |
ASML Holding NV | 3.23 | 320.5 Mil | Technology |
Hitachi Ltd | 2.49 | 247.2 Mil | Industrials |
UniCredit SpA | 2.46 | 243.8 Mil | Financial Services |
Constellation Software Inc | 2.01 | 199.4 Mil | Technology |
Taiwan Semiconductor Manufacturing Co Ltd | 1.97 | 195.1 Mil | Technology |
ITOCHU Corp | 1.63 | 161.9 Mil | Industrials |
Lvmh Moet Hennessy Louis Vuitton SE | 1.63 | 161.7 Mil | Consumer Cyclical |
AstraZeneca PLC | 1.60 | 158.3 Mil | Healthcare |
United States